SCHEMBL25848292

SCHEMBL25848292

C=C(C)C(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4OC)c(=O)oc3c2)C1(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
GLA P06280 1/20 0.38
NOD2 Q9HC29 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
MIF P14174 1/20 0.35
S1PR1 P21453 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 2/20 0.34
APAF1 O14727 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848281 0.93 NPC1 (0.35) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL25848290 0.92 STS (0.33) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL25848285 0.92 MAOB (0.36) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL21735057 0.91 S1PR1 (0.43) MAOAMAOBS1PR1PPARGPPARA
SCHEMBL22625059 0.91 KDM4E (0.36) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL25848291 0.90 THRB (0.39) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL25855295 0.89 STS (0.34) KDM4EALDH1A1LMNAHPGDGLA
SCHEMBL25848269 0.87 KDM4E (0.39) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL22625305 0.85 STS (0.33) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL22624922 0.85 KDM4E (0.38) KDM4EALDH1A1GAALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 KDM4E 4579/4885ALDH1A1 1851/4885GAA 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.